Gross Margin: A company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage. Calculated as: Gross Income / Total Revenues
Standard BioTools Inc. (LAB) had Gross Margin of 48.39% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$40.80M |
|
$-26.03M |
|
$21.05M |
|
$19.74M |
|
$73.77M |
|
$-32.97M |
|
$6.79M |
|
$-26.18M |
|
$-26.18M |
|
$-26.03M |
|
$-26.03M |
|
$-26.03M |
|
$-26.03M |
|
$-32.97M |
|
$-29.64M |
|
378.23M |
|
378.23M |
|
$-0.07 |
|
$-0.07 |
|
| Balance Sheet Financials | |
$344.02M |
|
$43.59M |
|
$235.58M |
|
$579.60M |
|
$56.24M |
|
$0.30M |
|
$68.77M |
|
$125.00M |
|
$454.60M |
|
$314.82M |
|
$454.60M |
|
379.09M |
|
| Cash Flow Statement Financials | |
$-30.28M |
|
$14.62M |
|
$-0.05M |
|
$168.82M |
|
$153.47M |
|
$-15.35M |
|
$9.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.12 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
|
Gross Margin |
48.39% |
-80.82% |
|
-80.82% |
|
-- |
|
-64.18% |
|
-63.81% |
|
$-35.34M |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
0.50 |
|
1.15 |
|
78.27 |
|
-5.73% |
|
-8.27% |
|
-4.49% |
|
-5.72% |
|
$1.20 |
|
$-0.09 |
|
$-0.08 |
|